Author: Chunxiao Li, Meiying Ning, Xiaodong Yao, Yankun Wang and Ying Liu
Publishing Date: 2016
Volume: 29 Issue: 5
Preparation and in vitro/in vivo evaluation of gestodene (GEST) intravaginal ring (IVR) formulations which can release a constant dose of GEST during 3 weeks were investigated. In present study a reservoir gestodene intravaginal ring, including a gestodene silicone elastomer core and the non-active silicone layer, was reported, which was manufactured by reaction injection moulding at 80oC for 20 min. The raw materials compatibility experiments showed that the silicone elastomer core carrier wouldn’t interact with drugs. In vitro release samples were determined by HPLC and the experiment was performed under sink conditions. The equation of cumulative release verse time was Y=64.76x+5.44 (r=0.9998), performing zero-order release at about the target dose of 60 μg/day over 21 days. Drug release increased with temperature elevating from 45 to 55oC, which could be attributed to optimizing the prescription. In addition, the pharmacokinetic and safety studies of gestodene intravaginal ring were evaluated in female New Zealand White rabbits. The GEST in plasma was analyzed by LC-MS/MS and the results proved that the correlation between in vitro and in vivo was relatively well.
KEYWORDS: Intravaginal ring; silicone elastomer; gestodene; pharmacokinetics.